Clinical status and implications of antimalarial drug resistance
- 1 February 2002
- journal article
- review article
- Published by Elsevier in Microbes and Infection
- Vol. 4 (2), 157-164
- https://doi.org/10.1016/s1286-4579(01)01523-4
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Mutations in the P. falciparum Digestive Vacuole Transmembrane Protein PfCRT and Evidence for Their Role in Chloroquine ResistanceMolecular Cell, 2000
- Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparumNature, 2000
- Cost-effectiveness of malaria control in sub-Saharan AfricaThe Lancet, 1999
- Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trialThe Lancet, 1999
- Central Role of Hemoglobin Degradation in Mechanisms of Action of 4-Aminoquinolines, Quinoline Methanols, and Phenanthrene MethanolsAntimicrobial Agents and Chemotherapy, 1998
- Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection.The American Journal of Tropical Medicine and Hygiene, 1998
- Access to Hematin: The Basis of Chloroquine ResistanceMolecular Pharmacology, 1998
- Mutations inPlasmodium falciparumDihydrofolate Reductase and Dihydropteroate Synthase and Epidemiologic Patterns of Pyrimethamine‐Sulfadoxine Use and ResistanceThe Journal of Infectious Diseases, 1997
- Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-lifeTransactions of the Royal Society of Tropical Medicine and Hygiene, 1993
- Drug-protein conjugates—XVIIIBiochemical Pharmacology, 1989